Understanding molecular causes of Fuchs corneal dystrophy
Molecular Dysregulation in Fuchs Corneal Endothelial Dystrophy
Researchers are looking for molecular signals that cause Fuchs corneal dystrophy to help develop new treatments for people with the condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-11400635 on NIH RePORTER |
What this research studies
This project examines the molecular signaling pathways in the corneal endothelial cells that fail in Fuchs, using laboratory experiments and analysis of corneal tissue samples. Scientists will compare affected and healthy tissues and use molecular tools to map which pathways are altered in the disease. By pinpointing these dysregulated signals, they aim to identify targets that could be blocked or fixed with drugs or gene-based approaches. The work is lab-based at the University of Iowa and may involve donated eye tissue or collaboration with clinics for sample collection.
Who could benefit from this research
Good fit: People diagnosed with Fuchs endothelial corneal dystrophy, especially those in early-to-moderate stages or willing to donate corneal tissue for research, would be the ideal candidates to contribute.
Not a fit: People without Fuchs or those whose disease is already end-stage and require urgent corneal transplantation may not see direct benefit.
Why it matters
Potential benefit: If successful, this work could lead to non-surgical treatments that slow or stop vision loss and reduce the need for corneal transplants.
How similar studies have performed: Genetic and molecular studies have previously identified some FECD-related pathways, but targeted therapies remain largely unproven and this approach is relatively novel.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Shyam, Rajalekshmy — University of Iowa
- Study coordinator: Shyam, Rajalekshmy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.